...
首页> 外文期刊>European journal of nuclear medicine >Role of 123I-IMP SPET in the early diagnosis of borderline chronic hydrocephalus after aneurysmal subarachnoid haemorrhage.
【24h】

Role of 123I-IMP SPET in the early diagnosis of borderline chronic hydrocephalus after aneurysmal subarachnoid haemorrhage.

机译:123I-IMP SPET在动脉瘤性蛛网膜下腔出血后交界性慢性脑积水的早期诊断中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic hydrocephalus after aneurysmal sub-arachnoid haemorrhage (SAH) is easily diagnosed in most cases. However, the diagnosis is sometimes difficult in borderline cases, in which (a) pathognomonic clinical deterioration due to hydrocephalus is masked by the neurological deficits caused in the acute stage of SAH and (b) ventricular enlargement is not so marked on CT scan. The purpose of this study was to investigate whether or not iodine-123 labelled N-isopropyl-p-iodo-amphetamine (123I-IMP) single-photon emission tomography (SPET) is of value for the early diagnosis of borderline chronic hydrocephalus after SAH. Fifteen patients who met the criteria of borderline chronic hydrocephalus were selected for the study, and underwent a shunt operation. The patients were divided into a shunt-effective group and a shunt-ineffective group according to neurological improvement after the shunt operation. 123I-IMP SPET was performed in the acute stage of SAH, within 1 week before the shunt operation, and 2 weeks after the shunt operation. Regional cerebral blood flow was estimated by the 123I-IMP autoradiographic method. Pre-shunting periventricular low-perfusion areas showed statistically significant differences between the two groups (P<0.05). In the shunt-effective group, peri-ventricular low-perfusion areas on pre-shunting SPET were significantly enlarged compared with those in the acute stage of SAH (P<0.05), and they were significantly reduced after the shunt operation (P<0.05). In the shunt-ineffective group, periventricular low-perfusion areas showed no significant changes during the course. These results suggest that periventricular low-perfusion areas enlarge in the early stage of chronic hydrocephalus after SAH, and that 123I-IMP SPET can be used for both the early diagnosis of borderline chronic hydrocephalus after SAH and the prediction of shunt effectiveness.
机译:在大多数情况下,很容易诊断出动脉瘤性蛛网膜下腔出血(SAH)后的慢性脑积水。但是,在边缘病例中有时诊断困难,其中(a)SAH急性期引起的神经功能缺损掩盖了因脑积水引起的病理性临床恶化,以及(b)CT扫描未显示室扩大。这项研究的目的是调查碘123标记的N-异丙基-对-碘-苯异丙胺(123I-IMP)单光子发射断层扫描(SPET)是否对早期诊断SAH后交界性慢性脑积水具有价值。选择符合边缘性慢性脑积水标准的15例患者进行研究,并进行分流手术。根据分流术后神经功能的改善,将患者分为分流有效组和分流无效组。 123I-IMP SPET在SAH的急性期,分流手术前1周内和分流手术后2周内进行。通过123I-IMP放射自显影方法估算局部脑血流量。分流前心室低灌注区在两组之间有统计学差异(P <0.05)。在分流有效组中,与SAH急性期相比,分流前SPET上的室周低灌注区域显着扩大(P <0.05),并且在分流手术后明显减少(P <0.05)。 )。在分流无效组中,脑室低灌注区在整个过程中无明显变化。这些结果表明,在SAH后慢性脑积水的早期,脑室周围的低灌注区域增大,并且123I-IMP SPET可用于SAH后边缘性慢性脑积水的早期诊断和分流效果的预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号